Ganga Pharmaceuticals Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 512,000 (50%) | — | ₹77 Cr |
| Retail | — | 512,000 (50%) | — | ₹77 Cr |
| Σ Total | — | 1,024,000 (100%) | — | ₹1,536 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 8,000 | ₹120,000 |
| Retail (Max) | 13 | 104,000 | ₹1,560,000 |
| S-HNI (Min) | 14 | 112,000 | ₹1,680,000 |
| B-HNI (Min) | 67 | 536,000 | ₹8,040,000 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Deployment of production capacity – 0.25
- 2 Marketing and Brand Building – 0.70
- 3 General Corporate Purpose – 0.30
- 4 Issue Expenses – 0.29
Company Overview
Incorporated in 1994, Ganga Pharmaceuticals Ltd (GPL) is engaged in production of quality Bulk Ayurvedic Medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines all over Maharashtra.
Company is manufacturing the following proprietary products:
1) Ampachan Vati;
2) Khadira Vati;
3) Nirmalaya churna
Company's products are available in liquid dosage form and solid dosage forms. Liquid dosage form includes Oil-based products and solid dosage forms includes Powder-based products, Tablets, and Pills.